Approvals/CIMA-AEMPS/BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Approved

STANDARD

BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION

Glaxosmithkline (Ireland) Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: aef709d85d10f9ac
Drug Cima Aemps Name: BLENREP 100 MG POLVO PARA CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1201474001
Holder Company Name: Glaxosmithkline (Ireland) Limited
Marketing Company Name: Glaxosmithkline S.A.
Holder Company Detail Path: /organization/glaxosmithkline-ireland-limited
Marketing Company Detail Path: /organization/glaxosmithkline-sa
Authorization Date: 2020-09-23
Dosage Form: POLVO PARA CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 100 mg
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: No
Company Name: Glaxosmithkline (Ireland) Limited
Company Detail Path: /organization/glaxosmithkline-ireland-limited

BELANTAMAB MAFODOTINA

100 mg

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Sep 23, 2020

Approval ID

aef709d85d10f9ac

Type

Standard